Key EU committee backs EU-wide restrictions on 'forever chemicals'

AFP
A technician in a French lab works on analysis of PFAs, used in products such as non-stick pans but which are feared harmful
A technician in a French lab works on analysis of PFAs, used in products such as non-stick pans but which are feared harmful
© AFP

The European Chemicals Agency (ECHA) said on Thursday that a second committee of experts had backed EU-wide restrictions on so-called "forever chemicals", citing risks to the environment and health.

The two opinions this year will inform the European Commission and mark a step towards restricting the use of the chemicals across Europe.

Perfluoroalkyl and polyfluoroalkyl substances, known as PFAS, are a group of more than 10,000 chemicals used in products such as non-stick pans, stain-proof carpets and some food packaging that have tainted food, water and wildlife.

The ECHA's Committee for Socio-Economic Analysis (SEAC) followed the Committee for Risk Assessment (RAC) in calling for action.

The SEAC "concluded that EU-wide action is needed to address the risks posed by PFAS, prevent market distortions and maintain a level playing field across the EU," the EU agency said in a statement.

"Both RAC and SEAC consider that existing regulatory measures are insufficient to control the emissions and risks arising from PFAS uses and therefore support further EU-wide action," it added.

SEAC supported "a ban with use-specific derogations" basing its assessment on "the socio-economic impacts of the proposed restriction" and the earlier opinion adopted by the RAC determining the growing risks that said the EU needed new regulations.

Maria Ottati, chair of the SEAC, said the opinions adopted this week -- which also support restrictions on certain chromium(VI) substances -- marked "an important milestone for SEAC".

"The committee has thoroughly scrutinised both restriction proposals, carefully balancing the societal costs and benefits of these restrictions to ensure they are proportionate and workable in practice," Ottati said. 

 

- Slow pace -

 

Chronic exposure to even low levels of PFAS has been linked to liver damage, high cholesterol, reduced immune responses, low birth weights and several cancers.

In a report published on Wednesday, the EU's European Court of Auditors warned that the bloc's approach to PFAS struggled to keep up with their use, exposing Europeans to the harmful chemicals.

The ECHA aims to submit the final opinions from the two expert committees to the European Commission in December, an agency spokesperson told AFP. The commission could then propose restrictions in 2027.  

EU spokeswoman Siobhan McGarry told reporters in Brussels that "we will of course, begin working on the restriction dossier and hope to then adopt it as soon as possible," describing it as "a very complex restriction dossier."

 

- Fierce lobbying -

 

Amelie Ott of the Brussels-based NGO European Environmental Bureau said in a statement that the European Commission "must respect the opinions of ECHA's independent experts".

The commission must "propose a broad restriction covering all PFAS across all sectors, with only well-justified, specific and time-limited derogations for essential applications where no alternatives are available", she continued.

Environmental groups have stepped up efforts to raise awareness of the chemicals, especially in Belgium and France where the contamination of water and soil by PFAS has sparked public outrage.

"Urgent action is needed to reduce the devastating impacts of PFAS on people's lives, the economy and the environment," Ott said.

The planned regulation has been met with fierce lobbying by industry groups seeking as many exemptions as possible for PFAS chemicals which are used in a wide array of items, from aerospace to components used in solar panels and cars.

Europe's pharmaceutical industry lobby EFPIA warned this year that companies would move their production to other countries unless there were "clear and durable derogations for medicines" in the draft rules.

Spectaris, the German lobby group for the optics, photonics and medical technology industries, has defended the use of fluoropolymers, a key material in medical devices and other high-tech equipment.

ank/jll/tw/st

Back to Top
CIM LOGO